Praxis Medical Insights

Clinical Presentation and Diagnosis

TRALI presents with non-cardiogenic pulmonary edema within 1-2 hours after transfusion, with key clinical features including hypoxemia, dyspnea, and hypotension, as noted by the American College of Chest Physicians 1
The mechanism involves donor leukocyte antibodies (HLA class I, class II, or granulocyte-specific antibodies) interacting with recipient neutrophils, causing acute respiratory distress and cardiovascular instability, according to the American Association of Blood Banks 1
TRALI is a leading cause of transfusion-related mortality despite being underdiagnosed and underreported, as stated by the National Institutes of Health 1

Stop the transfusion immediately and maintain IV access with normal saline, as recommended by the American College of Surgeons 1
Administer 100% oxygen to address the severe hypoxemia, as suggested by the American Thoracic Society 1
Call for help and prepare for potential intubation and mechanical ventilation, as advised by the Society of Critical Care Medicine 1

Maintain adequate blood pressure with IV fluid resuscitation using normal saline or lactated Ringer's solution, as recommended by the American College of Cardiology 1
Avoid diuretics, as they are ineffective and potentially harmful in TRALI, according to the European Society of Intensive Care Medicine 1
TRALI requires supportive care with oxygen therapy and critical care measures, not volume removal, as stated by the American College of Chest Physicians 1

Transfer to intensive care for continued monitoring and mechanical ventilation if needed, as recommended by the Society of Critical Care Medicine 3
Continue observation for at least 24 hours, as TRALI can evolve over the first 6-12 hours post-transfusion, according to the American Association of Blood Banks 1
Report the reaction to the blood bank to remove the implicated donor from the pool, as advised by the National Institutes of Health 1